• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逼尿肌反射亢进时对丙胺太林的膀胱测压反应:治疗意义

Cystometric response to propantheline in detrusor hyperreflexia: therapeutic implications.

作者信息

Blaivas J G, Labib K B, Michalik S J, Zayed A A

出版信息

J Urol. 1980 Aug;124(2):259-62. doi: 10.1016/s0022-5347(17)55398-7.

DOI:10.1016/s0022-5347(17)55398-7
PMID:7401243
Abstract

We studied 42 patients with urinary incontinence who demonstrated uninhibited detrusor contractions during cystometry. Each patient underwent urodynamic evaluation before and after the parenteral administration of propantheline bromide. Of these 42 patients 33 (79 per cent) had a positive response to propantheline: total abolition of uninhibited bladder contractions or 200 per cent increase in bladder capacity. Of these 33 patients 26 were treated with the oral drug and all but 1 had complete clinical response. Urinary retention occurred in half of the patients. These patients were managed with intermittent self-catheterization in addition to oral propantheline. None of the patients who failed to respond to the parenteral medication had a favorable response to the orally administered drug.

摘要

我们研究了42例尿失禁患者,这些患者在膀胱测压时表现出逼尿肌无抑制性收缩。每位患者在胃肠外给予溴丙胺太林前后均接受了尿动力学评估。在这42例患者中,33例(79%)对溴丙胺太林有阳性反应:无抑制性膀胱收缩完全消失或膀胱容量增加200%。在这33例患者中,26例接受了口服药物治疗,除1例患者外,其余患者均有完全的临床反应。一半的患者出现了尿潴留。除口服溴丙胺太林外,这些患者还通过间歇性自我导尿进行处理。对胃肠外用药无反应的患者中,没有一例对口服药物有良好反应。

相似文献

1
Cystometric response to propantheline in detrusor hyperreflexia: therapeutic implications.逼尿肌反射亢进时对丙胺太林的膀胱测压反应:治疗意义
J Urol. 1980 Aug;124(2):259-62. doi: 10.1016/s0022-5347(17)55398-7.
2
Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline.尿急失禁:戊噻嗪与安慰剂及丙胺太林的随机交叉试验
Med J Aust. 1996 Nov 4;165(9):473-6. doi: 10.5694/j.1326-5377.1996.tb138610.x.
3
Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia.奥昔布宁与丙胺太林治疗多发性硬化症合并逼尿肌反射亢进的疗效比较
J Urol. 1986 May;135(5):966-8. doi: 10.1016/s0022-5347(17)45940-4.
4
Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.肉毒杆菌A毒素治疗脊髓损伤患者逼尿肌反射亢进:抗胆碱能药物的新替代方案?初步结果。
J Urol. 2000 Sep;164(3 Pt 1):692-7. doi: 10.1097/00005392-200009010-00018.
5
Treatment of the unstable bladder with propantheline and imipramine.用丙胺太林和丙咪嗪治疗不稳定膀胱。
Aust N Z J Obstet Gynaecol. 1987 May;27(2):152-4. doi: 10.1111/j.1479-828x.1987.tb00969.x.
6
Oxybutinin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trial.奥昔布宁与丙胺太林治疗逼尿肌不稳定。一项患者自行调整剂量的试验。
Br J Obstet Gynaecol. 1989 May;96(5):607-12. doi: 10.1111/j.1471-0528.1989.tb03263.x.
7
Micturition urodynamic flow studies in children.儿童排尿尿动力学流量研究
Trans Am Assoc Genitourin Surg. 1977;69:8-11.
8
[Treatment with propantheline for urinary incontinence caused by bladder instability in the elderly].[丙胺太林治疗老年人膀胱不稳定引起的尿失禁]
An Med Interna. 1992 Mar;9(3):116-20.
9
Clinical and urodynamic effects of ephedrine in elderly incontinent patients.麻黄碱对老年尿失禁患者的临床及尿动力学影响。
J Urol. 1982 Dec;128(6):1250-2. doi: 10.1016/s0022-5347(17)53448-5.
10
Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.急性经皮胫后神经刺激对膀胱过度活动症的尿动力学影响
J Urol. 2003 Jun;169(6):2210-5. doi: 10.1097/01.ju.0000067446.17576.bd.

引用本文的文献

1
Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample.泌尿系统症状的药物治疗:基于社区样本评估未满足需求的程度。
BJU Int. 2009 Dec;104(11):1680-8. doi: 10.1111/j.1464-410X.2009.08686.x. Epub 2009 Jun 22.
2
Clinical pharmacology of old age syndromes.老年综合征的临床药理学
Br J Clin Pharmacol. 2003 Sep;56(3):261-72. doi: 10.1046/j.0306-5251.2003.01877.x.
3
Multiple Sclerosis: Symptomatic Treatment.
Curr Treat Options Neurol. 1999 Jul;1(3):221-238. doi: 10.1007/s11940-999-0005-9.
4
The lower urinary tract.下尿路
Br J Clin Pharmacol. 1982 Jun;13(6):761-73. doi: 10.1111/j.1365-2125.1982.tb01864.x.
5
A critical reappraisal of cystometry in neurogenic bladder diseases.
Urol Res. 1987;15(5):287-90. doi: 10.1007/BF00258197.
6
A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.一种钙阻滞剂和抗胆碱能药物(特罗地林)治疗逼尿肌反射亢进:一项安慰剂对照交叉试验
J Neurol Neurosurg Psychiatry. 1987 Oct;50(10):1331-6. doi: 10.1136/jnnp.50.10.1331.
7
Current concepts in the treatment of disorders of micturition.排尿障碍治疗的当前概念
Drugs. 1988 Apr;35(4):477-94. doi: 10.2165/00003495-198835040-00006.
8
Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis).多发性硬化症患者下尿路功能障碍的治疗。欧洲多发性硬化症性与泌尿系统疾病研究组(SUDIMS)委员会。
J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):986-9. doi: 10.1136/jnnp.55.11.986.